Neoadjuvant PD-1 blockade plus chemotherapy versus chemotherapy alone in locally advanced stage II-III gastric cancer: A single-centre retrospective study

BACKGROUND: PD-1 blockade has been shown to have promising efficacy and acceptable safety profiles in advanced and metastatic gastric cancer; however, the efficacy and safety of neoadjuvant PD-1 blockade-based immunotherapy plus chemotherapy in locally advanced gastric cancer (LAGC) remain uncertain...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuchen, Zhang, Chuantao, Hou, Helei, Zhang, Yuming, Jiang, Peng, Zhou, Hai, Wang, Lele, Zhou, Na, Zhang, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034143/
https://www.ncbi.nlm.nih.gov/pubmed/36934638
http://dx.doi.org/10.1016/j.tranon.2023.101657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034143/
https://www.ncbi.nlm.nih.gov/pubmed/36934638
http://dx.doi.org/10.1016/j.tranon.2023.101657

Ejemplares similares